Cargando…

Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

OBJECTIVES: The current study was aimed at examining SARS-CoV-2 immune responses following two doses of Comirnaty® COVID-19 vaccine among elderly people in nursing homes. METHODS: A prospective cohort study in a representative sample from nursing homes in Valencia (n = 881; males: 271, females 610;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albert, Eliseo, Burgos, Javier S., Peiró, Salvador, Salas, Dolores, Vanaclocha, Hermelinda, Giménez, Estela, Limón, Ramón, Alcaraz, María Jesús, Sánchez-Payá, José, Díez-Domingo, Javier, Navarro, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490129/ https://www.ncbi.nlm.nih.gov/pubmed/34619398 http://dx.doi.org/10.1016/j.cmi.2021.09.031

Ejemplares similares

SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine
por: Giménez, Estela, et al.
Publicado: (2022)

Cumulative incidence of SARS‐CoV‐2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
por: Camacho, Jorge, et al.
Publicado: (2022)

Seroprevalence of antibodies against SARS-CoV-2 in the Valencian Community (Spain) as of October 2022
por: García-Sempere, Aníbal, et al.
Publicado: (2023)

Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain
por: Sánchez-Saez, Francisco, et al.
Publicado: (2022)

Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population()
por: Camacho, Jorge, et al.
Publicado: (2023)

Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty® COVID-19 vaccine
por: Giménez, Estela, et al.
Publicado: (2022)

B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents
por: Torres, Ignacio, et al.
Publicado: (2021)

The effectiveness of mRNA vaccines to prevent SARS-CoV-2 infection and hospitalisation for COVID-19 according to the time elapsed since their administration in health professionals in the Valencian Autonomous Community (Spain)
por: Chico-Sánchez, Pablo, et al.
Publicado: (2022)

Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents
por: Sánchez-Sendra, Beatriz, et al.
Publicado: (2022)

Revision of Comirnaty precautions in Japan
Publicado: (2022)

No safety concerns with Comirnaty vaccine in pregnancy
Publicado: (2021)

Comirnaty va enfin affronter le variant Omicron
por: Manus, Jean-Marie
Publicado: (2022)

Etiology of bloodstream infections at a population level during 2013-2017 in the Autonomous Community of Valencia, Spain
por: Ruiz-Azcona, Laura, et al.
Publicado: (2020)

Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy)
por: Fano, Valeria, et al.
Publicado: (2022)

Early tolerability of Comirnaty vaccine in patients with chronic neurological diseases
por: Budowski, C., et al.
Publicado: (2021)

Booster son immunité avec Comirnaty : mode d'emploi
por: Manus, Jean-Marie
Publicado: (2021)

Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
por: Hein, Sascha, et al.
Publicado: (2021)

Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
por: Tan, Cheng Siang, et al.
Publicado: (2022)

Post-COMIRNATY(Ⓡ) Non-episodic Angioedema with Eosinophilia: An Elderly Case
por: Sato, Yu, et al.
Publicado: (2021)

Construction of an individual socioeconomic status index for analysing inequalities in colorectal cancer screening
por: Vanaclocha-Espí, Mercedes, et al.
Publicado: (2022)

A neurologist’s rhombencephalitis after comirnaty vaccination. A change of perspective
por: Walter, Alexander, et al.
Publicado: (2021)

Safety update on COVID-19 vaccine Comirnaty finds no new concerns
Publicado: (2021)

Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccine
por: Marcelino, João, et al.
Publicado: (2022)

Rhabdomyolysis after COVID-19 Comirnaty Vaccination: A Case Report
por: Ruijters, Veerle J., et al.
Publicado: (2022)

Effectiveness of Comirnaty(®) Vaccine and Correlates of Immunogenicity and Adverse Reactions: A Single-Center Prospective Case Series Study
por: Fernández-Lázaro, Diego, et al.
Publicado: (2022)

Spatio-temporal evolution of female lung cancer mortality in a region of Spain, is it worth taking migration into account?
por: Zurriaga, Oscar, et al.
Publicado: (2008)

Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®)
por: Edler, Carolin, et al.
Publicado: (2021)

Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rash
por: Stoyanov, Alex, et al.
Publicado: (2022)

Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination( )
por: Chua, Gilbert T, et al.
Publicado: (2021)

NZ's Medsafe reminder: pericarditis/myocarditis may occur after Comirnaty vaccination
Publicado: (2022)

Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status
por: Helle, François, et al.
Publicado: (2022)

Clinical, microbiological, and immunological aspects of healthy versus peri-implantitis tissue in full arch reconstruction patients: a prospective cross-sectional study
por: Ata-Ali, Javier, et al.
Publicado: (2015)

Data Resource Profile: The Valencia Health System Integrated Database (VID)
por: García-Sempere, Anibal, et al.
Publicado: (2020)

Pre-Drawn Syringes of Comirnaty for an Efficient COVID-19 Mass Vaccination: Demonstration of Stability
por: Selmin, Francesca, et al.
Publicado: (2021)

Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database()
por: Rochoy, Michaël, et al.
Publicado: (2022)

Brève : L’EMA évalue le vaccin Comirnaty chez les 5-11 ans
por: Manus, Jean-Marie
Publicado: (2021)

Booster COVID-19 vaccine comirnaty ignite supraventricular tachycardia in Wolff Parkinson White Syndrome
por: Kang, H.Y., et al.
Publicado: (2022)

Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16–29 years
por: Funk, Patrick R., et al.
Publicado: (2022)

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
por: Ireland, Georgina, et al.
Publicado: (2022)

Érythème pigmenté fixe après vaccin anti-COVID-19 Comirnaty® de Pfizer/BioNTech
por: Lellig, Elodie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_brsd0vubeimp6qnebkvbi5oluq